Surgery for peripheral artery disease (PAD) carries real risks, but for many patients the danger of not treating severely blocked leg arteries is greater than the danger of the procedure itself. In a large study of over 3,200 PAD surgeries, the overall complication rate was 30%, with most complications being wound-related. The 30-day mortality rate was 5% overall, though that number varied dramatically depending on how severe the disease was before surgery.
Understanding your personal risk means looking at the type of procedure, the stage of your disease, and your overall health going in. Here’s what the evidence shows.
The Most Common Complications
Wound complications are by far the most frequent problem after PAD surgery, occurring in about 19% of cases. These include infections at the incision or graft site, slow healing, and fluid buildup. Surgical complications like bleeding or graft failure account for roughly 6% of cases, and general medical complications (heart events, pneumonia, kidney problems) affect about 10%.
The 30-day mortality rate tells an important story about who faces the most danger. For patients with intermittent claudication, the milder form of PAD where legs hurt during walking but recover with rest, the death rate within 30 days of surgery was just 1%. For patients with acute limb ischemia, where blood flow is suddenly and severely reduced, that number jumped to 8%. The 30-day amputation rate followed a similar pattern: 0.5% for claudication patients versus 21% for those who already had gangrene. In other words, the sicker you are going into surgery, the higher the stakes.
Minimally Invasive vs. Open Bypass Surgery
There are two broad categories of PAD procedures, and they carry very different risk profiles. Minimally invasive endovascular procedures (angioplasty and stenting) involve threading a catheter through a blood vessel to open the blockage from inside. Open bypass surgery involves creating a new route for blood flow around the blocked artery using either your own vein or a synthetic graft.
Endovascular procedures are significantly safer in the short term. Studies comparing the two approaches show that in-hospital death rates are roughly 2% for catheter-based procedures compared to 9% for open surgery. Stroke risk drops to nearly zero with endovascular treatment versus about 5% with bypass. Heart attack during hospitalization also falls from around 6% with open surgery to about 1% with catheter-based treatment.
That said, bypass surgery sometimes offers better long-term durability, especially for complex or extensive blockages. The choice between the two isn’t simply about risk. It depends on where the blockage is, how long it extends, and whether you have a suitable vein that can be used as a graft. For below-the-knee bypasses, one-year graft patency (meaning the graft stays open and functional) is about 72 to 73% regardless of whether a vein or synthetic graft is used.
Who Faces the Highest Risk
Four factors consistently predict worse outcomes after PAD surgery: advanced age, heart disease, kidney disease, and poor overall health status. Patients with diabetes face compounding challenges because diabetes damages small blood vessels, slows wound healing, and frequently coexists with both heart and kidney disease. Research on diabetic patients with PAD shows that having multiple vascular conditions at the same time results in significantly worse survival and more cardiovascular events.
The type of anesthesia also matters. Regional anesthesia (numbing a large area of the body rather than putting you fully under) is associated with fewer heart and lung complications, shorter hospital stays, and lower mortality compared to general anesthesia. Despite this evidence, most patients still receive general anesthesia, often based on the surgical team’s experience and institutional practice. If you’re considered high risk, asking about regional anesthesia options is reasonable.
What Happens Without Surgery
For people with critical limb-threatening ischemia, the most advanced stage of PAD, the risks of doing nothing are stark. Without treatment, about 20 to 25% of these patients lose a limb within one year. A large analysis of over 1,500 untreated patients found that at 12 months, both the death rate and the amputation rate were 22%. After two years without revascularization, nearly a third of patients had died, mostly from cardiovascular disease, and 23% needed a major amputation.
Revascularization does improve these numbers. A real-world study comparing treated and untreated patients with critical limb disease found that surgery reduced the major amputation rate from 46.5% to 40.4%. Programs that use fast-track, team-based approaches to get patients treated quickly have achieved even better results, with major amputation rates as low as 1.6 to 2.3% over seven years.
Preparing for Surgery Safely
Much of the danger associated with PAD surgery can be reduced before you ever enter the operating room. Because PAD patients frequently have heart disease, your surgical team will assess your cardiovascular risk using standardized scoring tools and evaluate your physical fitness. A simple benchmark: if you can climb two flights of stairs without stopping, your functional capacity is generally adequate. If you can’t, additional heart testing may be needed.
Anemia is an independent risk factor for complications after surgery, so your team may check iron levels and treat any deficiency beforehand. Heart failure medications should be optimized in the weeks leading up to the procedure. If you’ve had a coronary stent placed in the past, elective PAD surgery is ideally delayed 6 to 12 months to allow your coronary stent to stabilize while you remain on blood thinners.
Recovery and What Comes After
Recovery timelines differ significantly between the two procedure types. After an endovascular procedure like angioplasty or stenting, many patients go home the same day or the next day. After open bypass surgery, expect a hospital stay of two to five days, with full recovery taking six to eight weeks. Most bypass patients can return to work within a few weeks, though leg swelling and fatigue may linger longer.
Surgery is not the end of treatment. You’ll need blood-thinning medications afterward to keep the repaired artery or graft open. After stenting, this typically means two blood-thinning medications taken together for two to six months. After bypass with a synthetic graft, a combination approach also appears to reduce the risk of graft failure and limb-threatening events compared to a single blood thinner alone. These medications carry their own risk of bleeding, so your care team will balance clot prevention against bleeding risk based on your individual situation.
Long-term success also depends on managing the underlying disease. PAD is driven by the same process that causes heart attacks and strokes: cholesterol buildup in artery walls. Smoking cessation, blood pressure control, cholesterol management, blood sugar regulation for diabetics, and regular walking all reduce the chance that new blockages will form or that repaired arteries will close again.